Future in cancer treatment. Precision medicine advances in oncology. 7

Future in cancer treatment. Precision medicine advances in oncology. 7

Future in cancer treatment. Precision medicine advances in oncology. 7

Can we help?

Denna webbplats är skyddad av reCAPTCHA och Googles integritetspolicy . Användarvillkor gäller.

What does the future hold for cancer treatment? What new insights will be translated into successful tumor treatments? Leading oncologist shares his vision on precision medicine cancer treatment.


The last question is very important. Dr. Anton Titov, MD. You've studied cancer research all your professional life. Dr. Anton Titov, MD. You see thousands of patients. Where do you see the future for medical oncology in the next 5 to 10 years? Dr. Anton Titov, MD. What kind of breakthroughs in cancer therapy would be expected? Dr. Anton Titov, MD. What breakthroughs might be unexpected for cancer patients in the next decade? Dr. Anton Titov, MD. We’ have had wonderful cancer treatment advances recently. For example, the immunotherapy and some of the targeted cancer therapies. We are now on the way to getting much better understanding of the tumors. In the past we looked only at simple DNA analysis. Within a few years we are looking at not only DNA but a combination of DNA, RNA, proteins maybe. We will try to get a much better understanding of the tumor. We are developing an understanding that we have to look not only at the specific unique primary tumor site. But we have to find genetic mutations at various metastatic tumors. It is going to be quite complicated to do all these calculations on a simple tumor in one patient. But this is what we will have to do. So that we could get into deep understanding of the specific tumor of a specific patient. By doing that we can recommend the best cancer treatment. By studying the genetics of the tumor, and genetics of the patient. Much more than genetics. Much more than genetics? Dr. Anton Titov, MD. Not just genetics but also what we call transcriptomics. Dr. Ido Wolf, MD. That means the RNA, proteomics, the protein levels, and metabolomics. That means the metabolic levels. We know that DNA is not enough. Dr. Ido Wolf, MD. We will have to combine all these complicated assays. So we can get to one conclusion about cancer treatment. Professor Wolf, thank you very much! Very interesting! Thank you! Thank you! Dr. Anton Titov, MD. You are welcome!

Future in esophageal cancer treatment. Precision medicine. Tumor genome sequencing. 10
$0
Chimeric antigen receptor T-cell therapy in multiple myeloma. CAR T-cell immunotherapy. 8
$0
Autologous stem cell transplantation in multiple myeloma. 6
$0
Multiple myeloma. Risk stratification criteria to select the best treatment for each patient. 5
$0
Multiple myeloma and bone marrow microenvironment. ‘Seed and soil’ concept in cancer progression. 3
$0
Cytokine storm. Genetic susceptibility. Part 1. 10
$0
Recently viewed Expert Conversations

Get your treatment plan refined to perfection by a panel of 3 to 10+ top doctors who are perfect for you.

Get your treatment plan refined to perfection by a panel of 3 to 10+ top doctors who are perfect for you.

Get your treatment plan refined to perfection by a panel of 3 to 10+ top doctors who are perfect for you.


Can we help?

We can find perfect surgeons or medical specialists to perform your treatment.

We can find perfect surgeons or medical specialists to perform your treatment.


How it works
We can find perfect surgeons or medical specialists to perform your treatment.